Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 3 | 2019 | 14 | 0.830 |
Why?
|
| Obesity, Morbid | 2 | 2019 | 17 | 0.660 |
Why?
|
| Weight Loss | 2 | 2019 | 124 | 0.490 |
Why?
|
| Macular Degeneration | 1 | 2013 | 27 | 0.450 |
Why?
|
| Vitamin K | 1 | 2012 | 6 | 0.430 |
Why?
|
| Parenteral Nutrition | 1 | 2012 | 11 | 0.430 |
Why?
|
| Warfarin | 1 | 2012 | 59 | 0.400 |
Why?
|
| Anticoagulants | 1 | 2012 | 97 | 0.400 |
Why?
|
| Aging | 1 | 2013 | 639 | 0.330 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2019 | 77 | 0.210 |
Why?
|
| Middle Aged | 6 | 2019 | 9642 | 0.170 |
Why?
|
| Hyperlipidemias | 1 | 2018 | 35 | 0.170 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2015 | 15 | 0.160 |
Why?
|
| Protein Multimerization | 2 | 2015 | 97 | 0.160 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2015 | 14 | 0.140 |
Why?
|
| Plant Proteins | 1 | 2015 | 93 | 0.130 |
Why?
|
| Vibrio | 1 | 2014 | 16 | 0.130 |
Why?
|
| Leptospira | 1 | 2014 | 22 | 0.130 |
Why?
|
| Female | 6 | 2019 | 19873 | 0.120 |
Why?
|
| Vitreous Body | 1 | 2013 | 11 | 0.120 |
Why?
|
| Injections | 1 | 2013 | 35 | 0.120 |
Why?
|
| Retinaldehyde | 1 | 2013 | 21 | 0.120 |
Why?
|
| Receptors, Adrenergic | 4 | 1979 | 11 | 0.110 |
Why?
|
| Visual Acuity | 1 | 2013 | 98 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 217 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta | 4 | 1979 | 33 | 0.110 |
Why?
|
| Vitamins | 1 | 2013 | 91 | 0.110 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 10 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 157 | 0.110 |
Why?
|
| Venous Thrombosis | 1 | 2012 | 27 | 0.110 |
Why?
|
| Zinc | 1 | 2013 | 114 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 233 | 0.110 |
Why?
|
| Aminoglycosides | 1 | 2011 | 6 | 0.100 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2011 | 3 | 0.100 |
Why?
|
| Serum Albumin | 1 | 2012 | 49 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2011 | 17 | 0.100 |
Why?
|
| Drug Resistance | 1 | 2012 | 93 | 0.100 |
Why?
|
| Comorbidity | 1 | 2013 | 606 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2013 | 196 | 0.100 |
Why?
|
| Life Style | 1 | 2013 | 288 | 0.100 |
Why?
|
| Male | 8 | 2019 | 18870 | 0.100 |
Why?
|
| Obesity | 1 | 2018 | 965 | 0.100 |
Why?
|
| Humans | 7 | 2019 | 34853 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2013 | 775 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 520 | 0.090 |
Why?
|
| Aged | 3 | 2019 | 6448 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 355 | 0.080 |
Why?
|
| Adult | 4 | 2019 | 11034 | 0.080 |
Why?
|
| Retrospective Studies | 1 | 2013 | 1961 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 2333 | 0.070 |
Why?
|
| Risk Factors | 1 | 2013 | 3414 | 0.060 |
Why?
|
| Crystallography, X-Ray | 2 | 2015 | 237 | 0.060 |
Why?
|
| Arabidopsis | 2 | 2015 | 88 | 0.060 |
Why?
|
| United States | 1 | 2013 | 3894 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2015 | 376 | 0.060 |
Why?
|
| Adolescent | 1 | 2013 | 5035 | 0.060 |
Why?
|
| Dextroamphetamine | 2 | 1979 | 10 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2015 | 751 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 63 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 8 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 26 | 0.040 |
Why?
|
| Calibration | 1 | 2018 | 55 | 0.040 |
Why?
|
| Simvastatin | 1 | 2018 | 28 | 0.040 |
Why?
|
| Cholesterol | 1 | 2019 | 194 | 0.040 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1977 | 13 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2018 | 131 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 173 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 406 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 841 | 0.040 |
Why?
|
| Brain | 3 | 1979 | 1268 | 0.040 |
Why?
|
| Phloem | 1 | 2015 | 2 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2015 | 61 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 901 | 0.030 |
Why?
|
| Arabidopsis Proteins | 1 | 2015 | 38 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1353 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 172 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 175 | 0.030 |
Why?
|
| Movement | 1 | 2014 | 86 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2014 | 350 | 0.030 |
Why?
|
| Glucose | 1 | 2014 | 217 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 249 | 0.030 |
Why?
|
| Alprenolol | 3 | 1978 | 3 | 0.030 |
Why?
|
| Pharmacists | 1 | 2011 | 53 | 0.020 |
Why?
|
| Rubidium | 1 | 1978 | 6 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1056 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 1978 | 22 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 1977 | 6 | 0.020 |
Why?
|
| Heart | 1 | 1977 | 178 | 0.020 |
Why?
|
| Rats | 4 | 1979 | 3261 | 0.020 |
Why?
|
| Microsomes | 2 | 1977 | 52 | 0.010 |
Why?
|
| Kinetics | 2 | 1979 | 650 | 0.010 |
Why?
|
| Animals | 5 | 1979 | 14307 | 0.010 |
Why?
|
| Doxepin | 1 | 1977 | 1 | 0.010 |
Why?
|
| Iprindole | 1 | 1977 | 1 | 0.010 |
Why?
|
| Desipramine | 1 | 1977 | 10 | 0.010 |
Why?
|
| Cocaine | 1 | 1979 | 219 | 0.010 |
Why?
|
| Ouabain | 1 | 1978 | 15 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1978 | 23 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1978 | 25 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1978 | 15 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 1977 | 30 | 0.000 |
Why?
|
| Melanoma | 1 | 1978 | 91 | 0.000 |
Why?
|
| Binding Sites | 1 | 1977 | 597 | 0.000 |
Why?
|
| Myocardium | 1 | 1977 | 224 | 0.000 |
Why?
|
| Dihydroalprenolol | 1 | 1979 | 6 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1979 | 107 | 0.000 |
Why?
|
| Cyclic AMP | 1 | 1979 | 125 | 0.000 |
Why?
|
| Mice | 1 | 1978 | 5668 | 0.000 |
Why?
|